P53 MUTATIONS AT A-T BASE-PAIRS IN ANGIOSARCOMAS OF VINYL CHLORIDE-EXPOSED FACTORY-WORKERS

被引:183
作者
HOLLSTEIN, M
MARION, MJ
LEHMAN, T
WELSH, J
HARRIS, CC
MARTELPLANCHE, G
KUSTERS, I
MONTESANO, R
机构
[1] INSERM,U271,LYON,FRANCE
[2] NCI,HUMAN CARCINOGENESIS LAB,BETHESDA,MD 20892
关键词
D O I
10.1093/carcin/15.1.1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mutations in the p53 tumor suppressor gene are commonly found in the major human cancers and the mutational spectrum in some cancer types is consistent with the genotoxic effects of the associated envirommental risk factors. Thus far there is little information on p53 mutations in cancers of factory workers with a history of carcinogen exposure in the workplace. Occupational exposure to vinyl chloride causes liver angiosarcomas (ASL) and also increases the risk of several other cancers. Loss of p53 function in osteo- and fibrosarcomas can occur by two different mechanisms, p53 mutation and amplification of the MDM2 gene. We examined tumors from five vinyl chloride-exposed patients, four with ASL and one with hepatocellular carcinoma (HCC), for evidence of MDM2 proto-oncogene amplification or p53 mutation in exons 5-8. Amplification of MDM2 was not found, but in two of the angiosarcomas an A:T to T:A missense mutation was detected. p53 sequence analysis of vinyl chloride associated cancers may provide valuable information on the relationship between carcinogen exposure and DNA damage in cancer-related genes.
引用
收藏
页码:1 / 3
页数:3
相关论文
共 16 条
  • [1] CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS
    BAKER, SJ
    FEARON, ER
    NIGRO, JM
    HAMILTON, SR
    PREISINGER, AC
    JESSUP, JM
    VANTUINEN, P
    LEDBETTER, DH
    BARKER, DF
    NAKAMURA, Y
    WHITE, R
    VOGELSTEIN, B
    [J]. SCIENCE, 1989, 244 (4901) : 217 - 221
  • [2] INDUCTION OF SPECIFIC BASE-PAIR SUBSTITUTIONS IN ESCHERICHIA-COLI TRPA MUTANTS BY CHLOROETHYLENE OXIDE, A CARCINOGENIC VINYL-CHLORIDE METABOLITE
    BARBIN, A
    BESSON, F
    PERRARD, MH
    BEREZIAT, JC
    KALDOR, J
    MICHEL, G
    BARTSCH, H
    [J]. MUTATION RESEARCH, 1985, 152 (2-3): : 147 - 156
  • [3] CREECH JL, 1974, J OCCUP ENVIRON MED, V16, P150
  • [4] IMMUNE-RESPONSE TO P53 IS DEPENDENT UPON P53/HSP70 COMPLEXES IN BREAST CANCERS
    DAVIDOFF, AM
    IGLEHART, JD
    MARKS, JR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (08) : 3439 - 3442
  • [5] P53 MUTATIONS IN HUMAN CANCERS
    HOLLSTEIN, M
    SIDRANSKY, D
    VOGELSTEIN, B
    HARRIS, CC
    [J]. SCIENCE, 1991, 253 (5015) : 49 - 53
  • [6] LADANYI M, 1993, CANCER RES, V53, P16
  • [7] LEHMAN TA, 1991, CANCER RES, V51, P4090
  • [8] THE P53 TUMOR SUPPRESSOR GENE
    LEVINE, AJ
    MOMAND, J
    FINLAY, CA
    [J]. NATURE, 1991, 351 (6326) : 453 - 456
  • [9] LI D, 1991, CARCINOGENESIS, V14, P169
  • [10] THE MDM-2 ONCOGENE PRODUCT FORMS A COMPLEX WITH THE P53 PROTEIN AND INHIBITS P53-MEDIATED TRANSACTIVATION
    MOMAND, J
    ZAMBETTI, GP
    OLSON, DC
    GEORGE, D
    LEVINE, AJ
    [J]. CELL, 1992, 69 (07) : 1237 - 1245